News
- Author:
- Heidi Splete
Publish date: November 5, 2018
Review of payment records shows some undisclosed payments of $10,000 or more.
News
- Author:
- Heidi Splete
Publish date: November 2, 2018
Brexanolone infusion called a game changer by some committee members in a 17-1 vote recommending agency approval.
News
- Author:
- Heidi Splete
Publish date: November 2, 2018
WASHINGTON – Many pediatric indications involve genetic disorders.
News
- Author:
- Heidi Splete
Publish date: November 1, 2018
The advisory panels voted 21-2 against recommending the combo drug as an add-on for refractory depression.
News
- Author:
- Heidi Splete
Publish date: October 30, 2018
Vaccine-averse parents claim allergies, autoimmune diseases to support medical exemptions for school entry.
News
- Author:
- Heidi Splete
Publish date: October 30, 2018
ACIP hears data on safety and immunogenicity as manufacturer pursues expanded license.
News
- Author:
- Heidi Splete
Publish date: October 30, 2018
Flu vaccine was consistently effective among pregnant women across locations, trimesters, and medical conditions....
News
- Author:
- Heidi Splete
Publish date: October 29, 2018
In the wake of increased pertussis rates, ACIP has reinstated a pertussis working group to address adult booster ...
Video
- Author:
- Heidi Splete
Publish date: October 26, 2018
WASHINGTON – Rare disease research continues to expand, but many patients struggle to access the latest treatment...
Video
- Author:
- Heidi Splete
Publish date: October 26, 2018
WASHINGTON – Primary care clinicians are important to the ongoing health of patients with rare diseases.
News
- Author:
- Heidi Splete
Publish date: October 25, 2018
New user-friendly format for adult and child/adolescent vaccination schedules features shorter titles, more table...
News
- Author:
- Heidi Splete
Publish date: October 24, 2018
ACIP votes unanimously to vaccinate homeless individuals against hepatitis A.
News
- Author:
- Heidi Splete
Publish date: October 23, 2018
WASHINGTON – Most patients with opsoclonus myoclonus syndrome experience ataxia, among multiple other symptoms.
News
- Author:
- Heidi Splete
Publish date: October 23, 2018
Evidence supports screening for abuse against reproductive age women, but not for elders or vulnerable adults.
News
- Author:
- Heidi Splete
Publish date: October 19, 2018
After 6 months, 57% of patients in the XR-naltrexone group were retained in treatment, compared with 28% of the oral group.
